Press Room

Press Clipping / May 11, 2020

Hovione helping out HSE and community groups with donations of hand sanitiser

Echo Live, May 11, 2020

A PHARMACEUTICAL company has donated hand sanitiser to the HSE as well as local organisations to help the fight against Covid-19.

Douglas GAA, camogie and ladies football clubs recently received a large donation of hand sanitiser for those that are helping out in their community during the pandemic.

Hovione is a contract pharmaceutical manufacturing company which helps bring new and off-patent drugs to market. 

Hovione, based in Ringaskiddy, has been manufacturing in Cork for 11 years and has more than  60 years experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Hovione employs more than 200 people in Cork and approximately 1,800 globally including Lisbon and Loures in Portugal; Macau in China and New Jersey in America.

Hovione initially began manufacturing hand sanitiser for the protection of team members on site with dispensers placed across the site. 

Since then the demand for hand sanitiser grew in our external community. This lead Hovione to appoint a project team to bring the manufacturing of hand sanitiser to distribution, so that it was readily available for donation to help protect various facilities and institutions across Ireland.

Key dates: April 11 – first day of Manufacturing - 17 days after the project kicked off.

April 20  – First batch of hand sanitiser was collected for use at St Stephen’s Hospital, Glanmire.

A spokesperson for the companys said: "A special thanks to the Hovione’s Project team, Site Leadership Team, Manufacturing and Warehouse Teams for all they have done to help with this fight against Covid-19. 

"A heartfelt thank you from all at Hovione must be given to the various suppliers who have helped us fight Covid-19 together - SciChem Laboratory Supplies, OCON Chemicals Ltd, Carbon Group, Quitmann O’Neill Packaging Ltd, Schuetz Packaging and South Coast Sales.

"To date Hovione have supplied 17,000 litres across Ireland to nursing homes, care facilities, charities and hospitals. Hovione are working closely with An Garda Síochána to safely distribute hand sanitiser to the HSE across Ireland with 11,000 litres of hand sanitiser  collected from site recently.

"On an international scale Hovione are distributing hand sanitiser free across all of our sites to support the local communities of each country we manufacture in."

Chairman of Douglas GAA Club, Aidan O'Connor thanks Hovione for their generous donation to the various clubs.

 

Read the article published at EchoLive.ie








Hovione helping out HSE and community groups with donations of hand sanitiser | Hovione
Rory Noonan, second left, receiving a donation of hand sanitiser from Hovione Éireann to Douglas GAA, Camogie and Ladies Football Clubs for members who are helping out in their local community. Representing Hovione Éireann were: Conor Crosbie, project manager; Willie Walsh, warehouse operator and Michelle McEvoy, analytical chemist. Picture: Barry O’Donoghue









 

Also in the Press Room

See All

Hovione is bringing momentum to the intranasal field after announcing that its lead single-use nasal dry powder device, developed in collaboration with Industrial Design Consultancy Ltd (IDC), is now available for commercial partnerships. The milestone marks the transition from prototype to a fully integrated intranasal drug delivery platform that spans Hovione’s end-to-end partnership capabilities–from API synthesis through advanced formulation and particle engineering to drug product manufacturing, including device supply and advanced analytical tools for nasal performance characterization. The platform’s single-use device is designed to be manufacturable at scale and to leverage existing advanced particle engineering and drug product manufacturing capabilities, a practical advantage that can shorten timelines to clinic and commercialization while reducing development risk and cost. The device’s patented mechanism supports targeted nasal deposition, including access to the upper olfactory region. This enables rapid systemic absorption and potential nose-to-brain delivery pathways that are increasingly important for CNS and emergency-use indications. Beyond the single-use format, Hovione and IDC are advancing a multi-dose variant to broaden applicability across dosing regimens and therapeutic areas. The collaboration is backed by an intellectual property portfolio and initial patent grants, positioning the platform as a turnkey option for pharma partners seeking a single integrated supplier for both drug substance and device. This development arrives as intranasal delivery gains traction for systemic, CNS and rapid-onset therapies. This is precisely the focus of the upcoming 4th Nasal Formulation & Delivery Summit, for which Hovione is a key sponsor. The annual summit unites formulation, delivery and product development leaders to tackle drug-device compatibility, translational preclinical models, and strategies for scalable, regulatory-ready intranasal programs. Hovione’s recent progress will be highly relevant to attendees looking to de-risk nose-to-brain and systemic intranasal programs. Read the full article at News-Medical.net    

Press Clipping

Hovione advances intranasal drug delivery with commercial-ready dry powder platform ahead of 4th Nasal Formulation & Delivery Summit

Jun 01, 2026